Hypothesis for the mode of action of roflumilast. Abbreviations: FeV 1... | Download Scientific Diagram
COPD exacerbations: defining their cause and prevention - The Lancet
The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients | European Respiratory Society
Functional respiratory imaging to assess the interaction between syste | COPD
Cardiac effects of current treatments of chronic obstructive pulmonary disease - The Lancet Respiratory Medicine
PDE4 inhibitors in COPD—a more selective approach to treatment - ScienceDirect
Pharmacological mechanism of roflumilast in ACO. Abbreviations: ACO,... | Download Scientific Diagram
Roflumilast-selective phosphodiesterase 4 inhibition increases... | Download Scientific Diagram
Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS - ScienceDirect
Functional respiratory imaging to assess the interaction between syste | COPD
DALIRESP® (roflumilast) Mechanism of Action | For HCPs
New Therapeutic Options for COPD - ppt video online download
Functional respiratory imaging to assess the interaction between syste | COPD
Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease
Roflumilast
Roflumilast 162401-32-3 | TCI EUROPE N.V.
Optimal treatment sequence in COPD: Can a consensus be found? | Pulmonology
Hypothesis for the mode of action of roflumilast. Abbreviations: FeV 1... | Download Scientific Diagram
Beyond corticosteroids: future prospects in the management of inflammation in COPD | European Respiratory Society
COPD (Chronic Obstructive Pulmonary Disease) - ppt video online download
Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease - Journal of Allergy and Clinical Immunology
Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease - Rabe - 2011 - British Journal of Pharmacology - Wiley Online Library
Frontiers | Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases | Pharmacology
